Company intelligence / Profile preview

Platinum Group Coatings

Los Angeles, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Platinum Group Coatings develops and commercializes ultra-low impedance electrode coatings—specifically the EP-IC coating—for use in neuromodulation therapies and biosensors. Their advanced platinum-iridium coated electrodes are designed to improve the performance of medical devices used in neuroscience research and clinical applications. The company is not a therapeutic developer but an enabler for device-based interventions. No direct clinical trial results are reported as they supply components rather than finished therapeutics or devices[1][2].

Modalities: DeviceElectrode material
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Platinum Group Coatings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platinum Group Coatings.

Explore the full profile